Loxo Oncology Inc
(NASDAQ : LOXO)

( )
LOXO PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
-0.37%86.271.3%$1352.68m
AMGNAmgen Inc.
0.97%203.881.2%$612.82m
GILDGilead Sciences, Inc.
0.77%69.180.9%$531.67m
LOXOLoxo Oncology Inc
0.11%233.5012.7%$525.80m
BIIBBiogen Inc.
-0.27%337.421.3%$408.79m
VRTXVertex Pharmaceuticals Incorporated
2.19%194.701.9%$323.01m
ILMNIllumina, Inc.
0.87%312.753.5%$317.65m
REGNRegeneron Pharmaceuticals, Inc.
0.35%418.842.6%$300.57m
ALXNAlexion Pharmaceuticals, Inc.
2.12%117.052.0%$212.97m
TSROTESARO, Inc.
0.03%74.9614.4%$167.91m
INCYIncyte Corporation
-0.32%78.422.5%$149.05m
AAgilent Technologies, Inc.
2.10%72.311.5%$147.46m
EXASExact Sciences Corporation
4.19%78.8025.3%$141.72m
SRPTSarepta Therapeutics, Inc.
1.22%122.8015.4%$135.00m
LGNDLigand Pharmaceuticals Incorporated
6.49%117.9023.1%$126.49m

Company Profile

Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing. The company was founded by Joshua H. Bilenker in May 2013 and is headquartered in Stamford, CT.